1,613 Shares in McKesson Corporation $MCK Purchased by Investment Research Partners LLC

Investment Research Partners LLC purchased a new stake in McKesson Corporation (NYSE:MCK) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,613 shares of the company’s stock, valued at approximately $1,303,000.

Several other hedge funds have also bought and sold shares of the stock. Cambria Investment Management L.P. boosted its stake in shares of McKesson by 17.2% during the 3rd quarter. Cambria Investment Management L.P. now owns 1,161 shares of the company’s stock worth $897,000 after acquiring an additional 170 shares in the last quarter. Vermillion & White Wealth Management Group LLC acquired a new position in shares of McKesson during the third quarter valued at approximately $33,000. ARQ Wealth Advisors LLC purchased a new position in shares of McKesson in the third quarter valued at approximately $4,445,000. CIBC Bancorp USA Inc. acquired a new stake in shares of McKesson in the third quarter worth approximately $13,278,000. Finally, Achmea Investment Management B.V. increased its position in shares of McKesson by 7.5% during the third quarter. Achmea Investment Management B.V. now owns 61,287 shares of the company’s stock worth $47,347,000 after purchasing an additional 4,260 shares in the last quarter. Hedge funds and other institutional investors own 85.07% of the company’s stock.

Insiders Place Their Bets

In other news, EVP Leann B. Smith sold 190 shares of the stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $945.00, for a total transaction of $179,550.00. Following the completion of the sale, the executive vice president owned 2,989 shares in the company, valued at approximately $2,824,605. This represents a 5.98% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Thomas L. Rodgers sold 276 shares of the firm’s stock in a transaction dated Monday, January 5th. The stock was sold at an average price of $816.18, for a total value of $225,265.68. Following the transaction, the executive vice president directly owned 2,268 shares in the company, valued at approximately $1,851,096.24. This represents a 10.85% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 3,868 shares of company stock valued at $3,743,820. 0.08% of the stock is owned by insiders.

McKesson Stock Performance

MCK stock opened at $920.48 on Thursday. The company’s 50 day moving average price is $900.55 and its 200 day moving average price is $830.63. The firm has a market capitalization of $112.75 billion, a price-to-earnings ratio of 26.47, a PEG ratio of 1.52 and a beta of 0.38. McKesson Corporation has a fifty-two week low of $637.00 and a fifty-two week high of $999.00.

McKesson (NYSE:MCK) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, beating analysts’ consensus estimates of $9.19 by $0.15. The company had revenue of $106.16 billion for the quarter, compared to analysts’ expectations of $105.98 billion. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.McKesson’s quarterly revenue was up 11.4% on a year-over-year basis. During the same period last year, the firm earned $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Equities analysts forecast that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Shareholders of record on Monday, March 2nd will be paid a $0.82 dividend. The ex-dividend date is Monday, March 2nd. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. McKesson’s payout ratio is currently 9.43%.

Analysts Set New Price Targets

A number of research analysts have weighed in on MCK shares. Raymond James Financial set a $970.00 price objective on McKesson in a report on Thursday, March 5th. Wall Street Zen lowered shares of McKesson from a “buy” rating to a “hold” rating in a report on Saturday, March 14th. Morgan Stanley reiterated an “overweight” rating and issued a $966.00 price objective on shares of McKesson in a research report on Thursday, January 29th. Leerink Partners reissued an “outperform” rating and issued a $1,085.00 target price on shares of McKesson in a research report on Thursday, March 5th. Finally, Evercore reaffirmed an “outperform” rating on shares of McKesson in a research report on Thursday, March 5th. Thirteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, McKesson has a consensus rating of “Moderate Buy” and an average price target of $960.93.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.